Working formulation for the standardization of definitions of infections in patients using ventricular assist devices

Hannan, Margaret M.; Husain, Shahid; Mattner, Frauke; Danziger‐Isakov, Lara; Drew, Richard J.; Corey, G. Ralph; Schueler, Stephan; Holman, William L.; Lawler, Leo P.; Gordon, Steve; Mahon, Niall; Herre, John M.; Gould, Kate; Montoya, José G.; Padera, Robert F.; Kormos, Robert L.; Conte, John V.; Mooney, Martha L.

doi:10.1016/j.healun.2011.01.717

Cited by 332 publications

(285 citation statements)

References 45 publications

Supporting

Mentioning

266

Contrasting

Unclassified

Order By: Relevance

“…This group includes infective endocarditis, bloodstream infections, mediastinitis, and sternal wound infection. 62 Computed tomography techniques can show the exact position and extent of inflammatory tissue, and this can be useful to understand the real relationship between the infection site and one portion of the VAD system.…”

Section: Vad-related Infectionsmentioning

confidence: 99%

“…61 In 2010, a core of group experts formed an International Society for Heart and Lung Transplantation Infection Diseases Working Group to develop agreed criteria for definitions of infections in VAD patients. 62 These definitions divided infections in patients with LVAD into three sections, ie, VADspecific infections, VAD-related infections, and non-VAD infections.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Ventricular assist devices for heart failure: a focus on patient selection and complications

Cipriani¹,

Simone²,

D’Angelo³

et al. 2014

RRCC

View full text Add to dashboard Cite

Heart transplantation represents the "gold standard" for the treatment of patients with end-stage heart failure, but remains challenged by inadequate donor supply, finite graft survival, and long-term complications arising from immunosuppressive therapy. In addition, a lot of patients waiting for a heart transplant experience clinical deterioration, and other patients become ineligible to undergo this treatment due to their age or relevant comorbidities. Left ventricular assist devices have emerged as a valid therapeutic option for advanced heart failure. In recent years, we have seen significant advances not only in the technologies available, but also in patient selection, indications for use, and management after implantation. Consequently, there has been an increase in the number of implants and an improvement in the survival rate and quality of life for these patients. At the same time, there are new challenges on the horizon. Patient selection is a difficult process, based on clinical and imaging parameters and risk scores, and more data are needed to refine patient selection criteria and the timing of the implant. Left ventricular assist device-related complications are still a serious problem, causing adverse events and hospital readmissions. Continuous progress in the development of these implantable devices, such as a further reduction in size and hopefully the abolition of the external driveline, will probably make ventricular assist devices an option also for less advanced stages of heart failure. Here, we discuss the current indications for left ventricular assist device implantation, patient selection criteria, and the most frequent complications associated with these devices.

show abstract

Section: Vad-related Infectionsmentioning

confidence: 99%

mentioning

confidence: 99%

Ventricular assist devices for heart failure: a focus on patient selection and complications

Cipriani¹,

Simone²,

D’Angelo³

et al. 2014

RRCC

View full text Add to dashboard Cite

show abstract

“…Infection related to LVAD is reported 11-20%. The importance of infections in the VAD patient prompted the creation of a comprehensive set of guidelines and definitions [39].…”

Section: Ventricular Assist Device (Vad) and Heart Failurementioning

confidence: 99%

Cardiomyocyte and Heart Failure

Nakano¹,

Muramatsu²,

Nishimura³

et al. 2012

Current Basic and Pathological Approaches to the Function of Muscle Cells and Tissues - From Molecules to Humans

View full text Add to dashboard Cite

“…4 Infections are usually classified as VAD-specific infections, VAD-related infections, and non-VAD infections in LVAD-recipients. 5 VAD-specific infections are related to the hardware (e.g., pump and cannula infection, pocket infection, or percutaneous driveline infection) whereas VAD-related infections refer to those that can also occur in patients who do not have VADs (e.g., infective endocarditis, blood stream infection, or mediastinitis).…”

mentioning

confidence: 99%

Diagnosis of infection in patients with left ventricular assist device: PET or SPECT?

Legallois

Manrique

2019

Journal of Nuclear Cardiology

View full text Add to dashboard Cite

Working formulation for the standardization of definitions of infections in patients using ventricular assist devices

Cited by 332 publications

References 45 publications

Ventricular assist devices for heart failure: a focus on patient selection and complications

Ventricular assist devices for heart failure: a focus on patient selection and complications

Cardiomyocyte and Heart Failure

Diagnosis of infection in patients with left ventricular assist device: PET or SPECT?

Contact Info

Product

Resources

About